During the past decade, John Hunter Children's Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 14 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Hunter Children's Hospital" #1 sponsor was "Children's Oncology Group" with 26 trials, followed by "National Cancer Institute (NCI)" with 12 trials sponsored, "Sydney Children's Hospitals Network" with 2 trials sponsored, "Donald Mabbott" with 1 trials sponsored and "John Hunter Children's Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Hunter Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "Children's Cancer Institute Australia" with 2 trials as a collaborator, "Australian & New Zealand Children's Haematology/Oncology Group" with 1 trials as a collaborator, "Garvan Institute of Medical Research" with 1 trials as a collaborator and "German Cancer Research Center" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "John Hunter Children's Hospital" are "B Acute Lymphoblastic Leukemia" (4 trials), "Down Syndrome" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Localized Resectable Neuroblastoma" (3 trials) and "Localized Unresectable Neuroblastoma" (3 trials). Many other conditions were trialed in "John Hunter Children's Hospital" in a lesser frequency.

Most popular intervention types in "John Hunter Children's Hospital" are "Drug" (32 trials), "Other" (29 trials), "Biological" (15 trials), "Radiation" (14 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Cyclophosphamide" (17 trials), "Etoposide" (16 trials), "Vincristine Sulfate" (16 trials) and "Doxorubicin Hydrochloride" (11 trials). Other intervention names were less common.

The vast majority of trials in "John Hunter Children's Hospital" are 43 trials for "All" genders.

Currently, there are NaN active trials in "John Hunter Children's Hospital". undefined are not yet recruiting, 17 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in John Hunter Children's Hospital, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in John Hunter Children's Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".